De Rose V, Rolla G, Bucca C, Ghio P, Bertoletti M, Baderna P, Pozzi E
Department of Clinical and Biological Sciences, University of Turin, Italy.
J Clin Invest. 1994 Nov;94(5):1840-5. doi: 10.1172/JCI117533.
To examine the role of adhesion molecules in T cell recruitment and activation during allergen-induced late asthmatic response (LAR), we evaluated the expression of lymphocyte function-associated antigen-1 alpha (LFA-1 alpha) and intercellular adhesion molecule-1 (ICAM-1) on peripheral blood T lymphocyte subsets from atopic asthmatic patients and their changes following allergen inhalation challenge. 12 atopic asthmatic patients were studied. Six patients showed only a single early response after allergen challenge, and six developed a dual response. At baseline, dual responders (DR) had a significantly higher expression of ICAM-1 on CD4+ and CD8+ T lymphocytes as compared with both single early responders (P < 0.005 and P < 0.02, respectively) and controls (P < 0.001, both comparisons). Allergen challenge was followed by a decrease of CD8+ ICAM-1+ T lymphocytes in all DR (P < 0.05) and of CD4+ ICAM-1+ T lymphocytes in four out of six DR, at the time of the LAR. At the same time, a significant rise in serum levels of the soluble form of ICAM-1 was observed in DR. These results suggest that peripheral blood immunoregulatory T lymphocytes are in a higher state of activation in DR as compared with early responders. The upregulation of ICAM-1 on these cells may be important in enhancing airway inflammation in patients with LAR.
为了研究黏附分子在变应原诱导的迟发性哮喘反应(LAR)期间T细胞募集和激活中的作用,我们评估了特应性哮喘患者外周血T淋巴细胞亚群上淋巴细胞功能相关抗原-1α(LFA-1α)和细胞间黏附分子-1(ICAM-1)的表达以及变应原吸入激发后它们的变化。研究了12例特应性哮喘患者。6例患者在变应原激发后仅出现单一的早期反应,6例出现双相反应。在基线时,与单一早期反应者(分别为P < 0.005和P < 0.02)和对照组(两次比较均为P < 0.001)相比,双相反应者(DR)的CD4 +和CD8 + T淋巴细胞上ICAM-1的表达明显更高。在LAR时,变应原激发后,所有DR患者的CD8 + ICAM-1 + T淋巴细胞均减少(P < 0.05), 6例DR患者中有4例的CD4 + ICAM-1 + T淋巴细胞减少。同时,在DR患者中观察到血清可溶性ICAM-1水平显著升高。这些结果表明,与早期反应者相比,DR患者外周血免疫调节性T淋巴细胞处于更高的激活状态。这些细胞上ICAM-1的上调可能在增强LAR患者的气道炎症中起重要作用。